In the last trading session, 5.83 million Kintara Therapeutics Inc (NASDAQ:KTRA) shares changed hands as the company’s beta touched 0.81. With the company’s per share price at $0.20 changed hands at $0.01 or 5.52% during last session, the market valuation stood at $11.32M. KTRA’s last price was a discount, traded about -2195.0% off its 52-week high of $4.59. The share price had its 52-week low at $0.08, which suggests the last value was 60.0% up since then. When we look at Kintara Therapeutics Inc’s average trading volume, we note the 10-day average is 8.49 million shares, with the 3-month average coming to 3.89 million.
Analysts gave the Kintara Therapeutics Inc (KTRA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended KTRA as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight. Kintara Therapeutics Inc’s EPS for the current quarter is expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Kintara Therapeutics Inc (NASDAQ:KTRA) trade information
Instantly KTRA was in green as seen at the end of in last trading. With action 17.53%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 20.58%, with the 5-day performance at 17.53% in the green. However, in the 30-day time frame, Kintara Therapeutics Inc (NASDAQ:KTRA) is 10.01% up. Looking at the short shares, we see there were 1.29 million shares sold at short interest cover period of 0.92 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 49.09%.
KTRA Dividends
Kintara Therapeutics Inc is expected to release its next quarterly earnings report in October.
Kintara Therapeutics Inc (NASDAQ:KTRA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.12% of Kintara Therapeutics Inc shares while 1.48% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.48%.
